Literature DB >> 21869744

HLA antibody specification using single-antigen beads--a technical solution for the prozone effect.

Martina Schnaidt1, Christof Weinstock, Marija Jurisic, Barbara Schmid-Horch, Andrea Ender, Dorothee Wernet.   

Abstract

BACKGROUND: Substantial progress in human leukocyte antigen antibody specification has been made by the introduction of Luminex single-antigen bead (SAB) assays. This progress was impaired when it turned out that this method is prone to a prozone effect leading to false-negative results in the case of high antibody titers. Testing serum and ethylenediaminetetraacetic acid (EDTA) plasma of one patient in parallel, we observed the prozone effect with the serum sample only. This led us to investigate complement component 1 (C1) as the cause of the prozone in SAB testing. We also found an easy way to overcome the prozone effect.
METHODS: Sera with a prozone effect were tested in the SAB assay, applying different methods of serum pretreatment to explore the parameters leading to the prozone.
RESULTS: The prozone was not observed when EDTA plasma or serum with EDTA added were tested. Further, addition of dithiothreitol, addition of C1 inhibitor, or heat inactivation of the sera abolished the prozone effect. Adding fresh nonimmune serum to heat-inactivated sera restored the prozone effect. Only beads showing a prozone were found to be covered with C1q.
CONCLUSION: Our observations are consistent with the hypothesis that dissociation or destruction of complement C1 eliminates the prozone effect. Addition of EDTA to serum of highly immunized patients is the easiest way to avoid false-negative results in SAB testing caused by a prozone effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21869744     DOI: 10.1097/TP.0b013e31822872dd

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  28 in total

1.  Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.

Authors:  Gwendaline Guidicelli; Florent Guerville; Sébastien Lepreux; Chris Wiebe; Olivier Thaunat; Valérie Dubois; Jonathan Visentin; Thomas Bachelet; Emmanuel Morelon; Peter Nickerson; Pierre Merville; Jean-Luc Taupin; Lionel Couzi
Journal:  J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 10.121

2.  False negative single antigen bead assay: Is it always an effect of prozone?

Authors:  Dharmendra Jain; Jui Choudhuri; Rajni Chauhan; Pranav Dorwal; Deepak Sharma; Aseem K Tiwari; Vimarsh Raina
Journal:  J Clin Lab Anal       Date:  2017-04-26       Impact factor: 2.352

3.  The utility of second single antigen bead assay: Clearing the water or stirring up mud?

Authors:  Harold C Sullivan; Scott M Krummey; Howard M Gebel; Robert A Bray
Journal:  Hum Immunol       Date:  2020-10-06       Impact factor: 2.850

4.  Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.

Authors:  Adriana Zeevi; John Lunz; Brian Feingold; Michael Shullo; Christian Bermudez; Jeffery Teuteberg; Steven Webber
Journal:  J Heart Lung Transplant       Date:  2012-11-09       Impact factor: 10.247

Review 5.  Utility of HLA Antibody Testing in Kidney Transplantation.

Authors:  Ana Konvalinka; Kathryn Tinckam
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

Review 6.  Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians.

Authors:  Carrie A Schinstock; Manish J Gandhi; Mark D Stegall
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

7.  Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.

Authors:  E F Reed; P Rao; Z Zhang; H Gebel; R A Bray; I Guleria; J Lunz; T Mohanakumar; P Nickerson; A R Tambur; A Zeevi; P S Heeger; D Gjertson
Journal:  Am J Transplant       Date:  2013-06-13       Impact factor: 8.086

8.  Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion.

Authors:  Nils Lachmann; Kremena Todorova; Harald Schulze; Constanze Schönemann
Journal:  Transfus Med Hemother       Date:  2013-05-08       Impact factor: 3.747

Review 9.  The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

Authors:  Stefan O Ciurea; Kai Cao; Marcelo Fernandez-Vina; Piyanuch Kongtim; Monzr Al Malki; Ephraim Fuchs; Leo Luznik; Xiao-Jun Huang; Fabio Ciceri; Franco Locatelli; Franco Aversa; Luca Castagna; Andrea Bacigalupo; Massimo Martelli; Didier Blaise; Rupert Handgretinger; Denis-Claude Roy; Paul O'Donnell; Asad Bashey; Hillard M Lazarus; Karen Ballen; Bipin N Savani; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2018-01-15       Impact factor: 5.483

10.  C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants.

Authors:  Rachael P Jackman; Jar-How Lee; Rui Pei; Douglas Bolgiano; Mila Lebedeva; Sherrill J Slichter; Philip J Norris
Journal:  Transfusion       Date:  2016-04-15       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.